Replies to post #12696 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>I hope they think about "pump head" when they design the CABG trial. They could find ATryn could help with something else, other than giving a buffer to heparin resistance.<

A good phase-3 trial is one that asks a specific question and answers it. If Ovation wants to pursue CABG/COG (a.k.a. pump head), it will almost certainly be in a separate trial from the one in CABG/HR.

[DewDiligence]

Addendum re CABG/HR vs CABG/COG:

The Venn diagram in #msg-29022959 depicts these as distinct indications, as it should.